I just got off the phone with an IR Rep at XRAY. He believes the stock decline is due to the non-appearance of interim CEO, Mark Thierer, at the JP Morgan Healthcare conference. This is true, according to my read of the JP Morgan notes from the event.

However, I’m not worried.

Mark bought $5.1 million of stock in November and the CFO Alexos bought $3.1 million too. He said the board has a fiduciary responsibility to pick the best CEO. That’s a given. XRAY is an outstanding company, a leader and pioneer in 3D modeling in dentistry.  I am not worried about Amazon entering this space at all.

Instead, I think this is a buying opportunity. We bought more today.